·   Log in

Archive for November 6th, 2009

Peg-interferon lambda has fewer side effects in hepatitis C patients: BMS & Zymogen

Friday, November 6, 2009 18:45

Pegylated interferon lambda 1a (also called IL-29) has fewer side-effects compared to its close cousin pegylated interferon alfa, besides higher level activity against hepatitis C virus infection, said developers of the drug Bristol-Myers Squibb and ZymoGenetics.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments
Tagged with:

Caraco launches generic ketorolac tromethamine (Acular) eye drops on first day of patent expiry in US

Friday, November 6, 2009 17:05

Caraco Pharmaceutical Laboratories, subsidiary of Indian generic firm Sun Pharma has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the US Food and Drug Administration.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with:

Higher sales, lower forex losses drive Torrent’s Q2 profits by 54% to Rs 74 crore

Friday, November 6, 2009 17:04

Torrent Pharmaceuticals Limited posted global sales at Rs. 465 crores for second quarter (Q2) ending 30th September, 2009, up by 16% from Rs 400 crores of the comparable quarter, driven by both domestic and overseas markets.

This was posted under category: Industry  |  Read Full Story  |  0 Comments

Aurobindo gets US FDA approval for generic lamotrigine (Lamictal) pills

Friday, November 6, 2009 14:48

Indian API and generics firm Aurobindo Pharma LtdĀ  has received the final approval for selling a generic version of the epilepsy drug, lamotrigineĀ  from the U.S Food and Drug Administration.

This was posted under category: Industry  |  Read Full Story  |  0 Comments

Wyeth suspends Prevnar pneumococcal vaccine batch following deaths of infants in The Netherlands

Friday, November 6, 2009 13:21

Wyeth's Prevnar vaccine trials were suspended in India last year after reports of infant death

This was posted under category: Pharma  |  Read Full Story  |  0 Comments